Search Results - Liam, Chong-Kin
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label,... by Wu, Y-L, Zhou, C.., Liam, Chong-Kin, Wu, G., Liu, X., Zhong, Z., Lu, S., Cheng, Y., How, Soon Hin, ., et al.
Published 2015Get full text
Get full text
Get full text
-
5
Epidermal growth factor receptor (EGFR) mutations are the main oncogenic driver mutation in adenocarcinoma in never-smokers - findings from the emlan study by Liam, Chong Kin, Alex, Leow Hwong Ruey, How, Soon Hin, Pang, YK, Chua, Keong Tiong, Lai, NL, Kuan, Yeh Chunn, Jayalakshimi, P, Pathmanathan, Rajadurai
Published 2012Get full text
Get full text
-
6
Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic Malaysian patient population by Liam, Chong-Kin, Leow, Hwong-Ruey, How, Soon Hin, Pang, Yong-Kek, Chua, Keong-Tiong, Lim, Boon-Khaw, Lai, Nai-Lang, Kuan, Yeh-Chunn, Pailoor, Jayalakshmi, Rajadurai, Pathmanathan
Published 2014Get full text
Get full text
Get full text
-
7
Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic So... by Rajadurai, Pathmanathan, Cheah, Phaik Leng, How, Soon Hin, Liam, Chong Kin, Ahmad Annuar, Muhammad Azrif, Omar, Norhayati, Othman, Noriah, Mohd Marzuki, Nurhayati, Pang, Yong Kek, Ahmad Bustamam, Ros Suzanna, Tho, Lye Mun
Published 2019Get full text
Get full text
Get full text